Virtual Heart Care

Background: Sacubitril/valsartan (Entresto®) reduces mortality and heart failure (HF) admissions in NYHA Class II/III HF with reduced ejection fraction (HFrEF).

Introduction: Early bystander initiated cardiopulmonary resuscitation (BCPR) is a key link in the cardiac arrest chain of survival. Prior work

Background: For patients presenting with ST segment elevation myocardial infarction (STEMI), shorter door-to-balloon (D2B) times are associated with lower mortality,

Background: Cardiovascular disease (CVD) remains the number one cause of death amongst women. There has been much effort put forth

Background: Recurrent Myocardial Infarction (MI) after an index MI is a cause for considerable morbidity and mortality. However, the underlying

Background: Cardiovascular disease is the leading cause of mortality in the United States. Approximately 25% of total deaths in the

Introduction: Aging population and recent opioid epidemic have contributed to increase incidence and cost of Infective endocarditis (IE). We aimed

Background: In 2018, CMS required shared decision-making (SDM) with a decision (DA) prior to implantation of a primary prevention cardioverter